SomaLogic Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SomaLogic Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7300
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma, serum, CSF, tissue homogenate, cell lysates and conditioned cell media. SomaLogic’s SOMAscan assay is a protein biomarker discovery and development tool for protein measurement solutions. It offers protein-measurement assays, kits, and reagents for life science and biopharma researchers. The company serves biological and medical science sectors. SomaLogic is headquartered in Boulder, Colorado, the US.

SomaLogic Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SomaLogic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SomaLogic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SomaLogic Inc, Medical Equipment, Deal Details 10
Venture Financing 10
SomaLogic Raises Funds through Venture Financing 10
SomaLogic Raises USD44.9 in Venture Financing 11
SomaLogic Raises USD163 Million in Venture Financing 12
Somalogic Raises USD16.5 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
Private Equity 15
SomaLogic Raises USD200 Million in Financing Round 15
Visium Healthcare Partners to Invest up to USD60.5 Million in SomaLogic 16
Partnerships 17
SomaLogic Enters into Licensing Agreement with GNS Healthcare 17
University of Oxford Enters into Agreement with SomaLogic 18
SomaLogic Enters into Agreement with Bristol-Myers Squibb 19
SomaLogic Extends Co-Development Agreement with Novartis 20
Children’s Hospital Enters into Co-Development Agreement with SomaLogic 21
SomaLogic Enters into Co-Marketing Agreement with NEC for SOMAscan Assay 22
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 23
SomaLogic Inc – Key Competitors 24
SomaLogic Inc – Key Employees 25
SomaLogic Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Corporate Communications 27
Apr 02, 2018: Melody Harris, J.D., Appointed Chief Legal Officer of SomaLogic 27
Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer 28
Other Significant Developments 29
Feb 06, 2018: SomaLogic teams with Leeds Centre for Personalised Medicine and Health to deliver SOMAscan platform in clinical healthcare 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
SomaLogic Inc, Medical Equipment, Key Facts 2
SomaLogic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SomaLogic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Deals By Market, 2012 to YTD 2018 8
SomaLogic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SomaLogic Raises Funds through Venture Financing 10
SomaLogic Raises USD44.9 in Venture Financing 11
SomaLogic Raises USD163 Million in Venture Financing 12
Somalogic Raises USD16.5 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
SomaLogic Raises USD200 Million in Financing Round 15
Visium Healthcare Partners to Invest up to USD60.5 Million in SomaLogic 16
SomaLogic Enters into Licensing Agreement with GNS Healthcare 17
University of Oxford Enters into Agreement with SomaLogic 18
SomaLogic Enters into Agreement with Bristol-Myers Squibb 19
SomaLogic Extends Co-Development Agreement with Novartis 20
Children’s Hospital Enters into Co-Development Agreement with SomaLogic 21
SomaLogic Enters into Co-Marketing Agreement with NEC for SOMAscan Assay 22
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 23
SomaLogic Inc, Key Competitors 24
SomaLogic Inc, Key Employees 25

List of Figures
SomaLogic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SomaLogic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SomaLogic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SomaLogic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SomaLogic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SomaLogic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SomaLogic Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ultra Petroleum Corp.:企業の戦略・SWOT・財務情報
    Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report Summary Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Beacon Discovery Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Beacon Discovery Inc (Beacon Discovery) is an independent drug discovery incubator that focuses on identifying and advancing molecules targeting G-Protein Coupled Receptors (GPCRs) from concept to clinic. The company works in collaboration with pharma and biotech companies to discover and de …
  • Commercial Metals Co:戦略・SWOT・企業財務分析
    Commercial Metals Co - Strategy, SWOT and Corporate Finance Report Summary Commercial Metals Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, mines, manages, produces and develops oil and gas properties in Western …
  • HLL Lifecare Ltd:企業の製品パイプライン分析
    Summary HLL Lifecare Ltd (HLL) is a manufacturer of natural rubber latex condoms. The company offers products such as condoms, tubal rings, synthetic braided and coated absorbable suture, monofilament polydioxanone surgical suture, synthetic absorbable surgical suture, blood bank refrigerator, steri …
  • ContourGlobal plc (GLO):企業の財務・戦略的SWOT分析
    ContourGlobal plc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Epigenomics AG (ECX)-医療機器分野:企業M&A・提携分析
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Innospec Inc. (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …
  • China Communications Construction Co Ltd:戦略・SWOT・企業財務分析
    China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Celsion Corp (CLSN):医療機器:M&Aディール及び事業提携情報
    Summary Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), T …
  • Vista Outdoor Inc:戦略・SWOT・企業財務分析
    Vista Outdoor Inc - Strategy, SWOT and Corporate Finance Report Summary Vista Outdoor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mediclinic International Plc (MDC):企業の財務・戦略的SWOT分析
    Mediclinic International Plc (MDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • La Jolla Pharmaceutical Company (LJPC):企業の財務・戦略的SWOT分析
    La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Manitoba Hydro-Electric Board:企業の発電所・SWOT分析2018
    Manitoba Hydro-Electric Board - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Osprey Medical Inc (OSP):企業の財務・戦略的SWOT分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • American Greetings Corporation:企業の戦略的SWOT分析
    American Greetings Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • NovoCure Ltd (NVCR):企業の製品パイプライン分析2018
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆